Clinical Trials Browser

Anovulation, Insulin Resistance, Polycystic Ovary Syndrome, Hyperandrogenism, Glucose Intolerance

NCT07298564 2025-12-23

Effect of Magnesium and Levocarnitine on Metabolic and Clinical Outcomes in Women With Polycystic Ovarian Syndrome (PCOS)

Phase NA Recruiting

84 enrolled

Hirsutism, Insulin Resistance, Polycystic Ovary Syndrome, Hyperandrogenism, Dyslipidemias

NCT03819140 2025-11-14

CCOUP

Phase 4 Completed

51 enrolled 15 charts

Polycystic Ovary Syndrome, Hyperandrogenism

NCT00929006 2025-08-05

CRM003

Phase EARLY_PHASE1 Recruiting

36 enrolled

Polycystic Ovary Syndrome, Hyperandrogenism

NCT03068910 2025-08-05

CRM008

Phase EARLY_PHASE1 Recruiting

32 enrolled

Polycystic Ovary Syndrome, Hyperandrogenism

NCT04723862 2025-08-05

CBS010

Phase EARLY_PHASE1 Recruiting

32 enrolled

Polycystic Ovary Syndrome, Hyperandrogenism

NCT03229408 2025-06-10

TIN-PCOS-AOD

Phase 2 Completed

60 enrolled 28 charts

Anovulation, Inflammation, Insulin Resistance, Polycystic Ovary Syndrome, Hyperandrogenism

NCT01889199 2025-01-10

Androgen Excess as a Cause for Adipogenic Dysfunction in PCOS Women

Phase 2 Completed

23 enrolled 12 charts

Amenorrhea, Anovulation, Hirsutism, Oligomenorrhea, Polycystic Ovary Syndrome, Hyperandrogenism

NCT02647827 2024-10-09

PIAII

Phase 2 Recruiting

303 enrolled

Insulin Resistance, Polycystic Ovary Syndrome, Hyperandrogenism

NCT02523898 2024-04-25

Metformine and CC Compared With Placebo and CC for Induction Ovulation in PCOS Patients With Insulin Resistant

Phase 2 Terminated

388 enrolled

Infertility, Polycystic Ovary Syndrome, Hyperandrogenism

NCT01428089 2023-11-02

Suppression of Daytime and Nighttime Luteinizing Hormone Frequency by Progesterone

Phase 1 Unknown

40 enrolled

Polycystic Ovary Syndrome, Hyperandrogenism

NCT01421810 2023-10-27

CBS001

Phase NA Unknown

80 enrolled

Other

Obesity, Polycystic Ovary Syndrome, Hyperandrogenism

NCT04075149 2023-10-27

CBS009

Phase EARLY_PHASE1 Unknown

24 enrolled

Polycystic Ovary Syndrome, Hyperandrogenism

NCT05647356 2022-12-12

REFUEL PCOS

Phase NA Unknown

16 enrolled

Metabolic Diseases, Polycystic Ovary Syndrome, Hyperandrogenism

NCT02460445 2022-07-27

Phlebotomy and Polycystic Ovary Syndrome

Phase NA Completed

37 enrolled

Insulin Resistance, Polycystic Ovary Syndrome, Hyperandrogenism, Metabolic Syndrome, Primary Dysautonomias

NCT04006171 2021-11-05

CNP

Phase NA Completed

90 enrolled 21 charts

Menstruation Disturbances, Polycystic Ovary Syndrome, Hyperandrogenism

NCT04645745 2021-01-14

Myo-inositol, Alpha-Lactalbumin and Folic Acid Treatment in PCOS

Phase NA Completed

36 enrolled

Polycystic Ovary Syndrome, Hyperandrogenism

NCT03152591 2021-01-05

PCOS

Phase 2 Completed

29 enrolled 24 charts

Other

Insulin Resistance, Obesity, Polycystic Ovary Syndrome, Hyperandrogenism, Overweight

NCT04453306 2020-07-01

Treatment of Obesity With Topiramate in Patients With Polycystic Ovary Syndrome

Phase 4 Unknown

80 enrolled

Other

Obesity, Polycystic Ovary Syndrome, Hyperandrogenism

NCT02052479 2019-10-07

Insulin Differences Between African-American and Caucasian Female Adolescents With Polycystic Ovary Syndrome (PCOS)

Phase NA Terminated

12 enrolled

Hirsutism, Insulin Resistance, Polycystic Ovary Syndrome, Hyperandrogenism

NCT01428193 2018-06-04

Effects of Androgen Blockade on Sensitivity of the GnRH Pulse Generator to Suppression by Estradiol and Progesterone

Phase NA Terminated

4 enrolled 5 charts

Polycystic Ovary Syndrome, Hyperandrogenism

NCT03383484 2017-12-26

Use of Osteopathic Principles for Nonpharmacologic, Therapeutic Interventions in Women With Polycystic Ovary Syndrome

Phase NA Completed

45 enrolled

Polycystic Ovary Syndrome, Hyperandrogenism

NCT03088046 2017-03-23

Circulating Androgen Levels Are Not Affected by the Administration of Vaginal Micronized Progesterone for Withdrawal Bleeding in Patients With Polycystic Ovarian Syndrome

Phase NA Completed

15 enrolled

Anovulation, Polycystic Ovary Syndrome, Hyperandrogenism

NCT01489319 2017-02-10

ELI-ROAS

Phase 1 Terminated

47 enrolled

Inflammation, Insulin Resistance, Polycystic Ovary Syndrome, Hyperandrogenism

NCT02651636 2016-01-11

Combined Therapy With Myo-inositol and Alpha-Lipoic Acid in PCOS Women

Phase NA Completed

40 enrolled

Polycystic Ovary Syndrome, Hyperandrogenism

NCT02027337 2014-11-21

Hemocoagulation and Lipoperoxidation in Women Using Combined Oral Contraceptives, Correction by Antioxidants

Phase 4 Unknown

200 enrolled

Menstruation Disturbances, Polycystic Ovary Syndrome, Hyperandrogenism

NCT00988078 2012-06-26

Effects of Metformin and Oral Hormonal Contraceptive in Adolescents With Polycystic Ovary Syndrome

Phase NA Unknown

90 enrolled

Insulin Resistance, Polycystic Ovary Syndrome, Hyperandrogenism, Metabolic Syndrome

NCT01526616 2012-02-06

Spironolactone Plus Metformin in Polycystic Ovary Syndrome

Phase NA Completed

56 enrolled

Polycystic Ovary Syndrome, Hyperandrogenism, Metabolic Syndrome

NCT01511822 2012-01-19

Clinical, Metabolic and Endocrine Effects of the Treatment With Drospirenone and Ethinyl Estradiol Alone or in Combination With Myo-inositol in Young Women With Polycystic Ovary Syndrome (PCOS) and Insulin Resistance

Phase 4 Completed

Insulin Resistance, Polycystic Ovary Syndrome, Hyperandrogenism

NCT00428311 2007-01-31

Effects of Metformin vs Oral Contraceptives on CV Risk Markers in PCOS

Phase 4 Completed

50 enrolled

Hirsutism, Polycystic Ovary Syndrome, Hyperandrogenism

NCT00413179 2006-12-19

The Effect of Metformin Added to Clomiphene Citrate on Pregnancy Rates in Hyperandrogenic, Chronic Oligoovulatory or Anovulatory Women

Phase 3 Completed

56 enrolled

Anovulation, Infertility, Polycystic Ovary Syndrome, Hyperandrogenism

NCT00317928 2006-10-11

Efficacy of Metformin in PCOS: Metabolic and Hormonal Factors

Phase NA Unknown

50 enrolled

Polycystic Ovary Syndrome, Hyperandrogenism, Metabolic Syndrome

Clinical Trials

INSUPP-PCOS

Effect of Magnesium and Levocarnitine on Metabolic and Clinical Outcomes in Women With Polycystic Ovarian Syndrome (PCOS)

CCOUP

CRM003

CRM008

CBS010

TIN-PCOS-AOD

Androgen Excess as a Cause for Adipogenic Dysfunction in PCOS Women

PIAII

Metformine and CC Compared With Placebo and CC for Induction Ovulation in PCOS Patients With Insulin Resistant

Suppression of Daytime and Nighttime Luteinizing Hormone Frequency by Progesterone

CBS001

CBS009

REFUEL PCOS

Phlebotomy and Polycystic Ovary Syndrome

CNP

Myo-inositol, Alpha-Lactalbumin and Folic Acid Treatment in PCOS

PCOS

Treatment of Obesity With Topiramate in Patients With Polycystic Ovary Syndrome

Insulin Differences Between African-American and Caucasian Female Adolescents With Polycystic Ovary Syndrome (PCOS)

Effects of Androgen Blockade on Sensitivity of the GnRH Pulse Generator to Suppression by Estradiol and Progesterone

Use of Osteopathic Principles for Nonpharmacologic, Therapeutic Interventions in Women With Polycystic Ovary Syndrome

Circulating Androgen Levels Are Not Affected by the Administration of Vaginal Micronized Progesterone for Withdrawal Bleeding in Patients With Polycystic Ovarian Syndrome

ELI-ROAS

Combined Therapy With Myo-inositol and Alpha-Lipoic Acid in PCOS Women

Hemocoagulation and Lipoperoxidation in Women Using Combined Oral Contraceptives, Correction by Antioxidants

Effects of Metformin and Oral Hormonal Contraceptive in Adolescents With Polycystic Ovary Syndrome

Spironolactone Plus Metformin in Polycystic Ovary Syndrome

Clinical, Metabolic and Endocrine Effects of the Treatment With Drospirenone and Ethinyl Estradiol Alone or in Combination With Myo-inositol in Young Women With Polycystic Ovary Syndrome (PCOS) and Insulin Resistance

Effects of Metformin vs Oral Contraceptives on CV Risk Markers in PCOS

The Effect of Metformin Added to Clomiphene Citrate on Pregnancy Rates in Hyperandrogenic, Chronic Oligoovulatory or Anovulatory Women

Efficacy of Metformin in PCOS: Metabolic and Hormonal Factors